×

img Accessibility Controls

Technologies Banner

All Technologies

Biomarker for Rheumatic Heart Disease (RHD)- Prototype is Ready for Commercialization

Project Overview

It is a protein based biomarker, it is detected in serum and urine, This test kit would help measurement of clinical activity in quiescent rheumatic heart disease, post penicillin treatment and overall management of the disease.

Benefits

Measrement of clinical activityin RHD, prognosis and overall management of rhheumatic heart disease.

Source

Quick Information
Thrust Areas
Medical Sciences
Focus Area
Rheumatic Heart Disease
Source Title
Output
TRL: Technology Readiness Level
Lab Validation
Patent
IN319303, ZA201302538
arrowtop
Latest Updates
Loading…